MoneyWorks4Me

Vivanza Biosciences - Quaterly Results

06 Feb 2024 Evaluate
The sales slipped to Rs. 33.66 millions for the December 2023 quarter as against Rs. 48.01 millions during the year-ago period.Net Profit of the company move down -56.35% to Rs. 1.82  millions from Rs. 4.17 millions  in the same quarter last year.Operating profit for the quarter ended December 2023 decreased to 2.85 millions as compared to 5.29 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 33.66 48.01 -29.89 121.14 81.88 47.95 142.07 91.48 55.30
Other Income 0.18 0.10 80.00 0.84 2.62 -67.94 3.87 8.28 -53.26
PBIDT 2.85 5.29 -46.12 10.18 9.40 8.30 11.08 8.77 26.34
Interest 1.02 1.11 -8.11 3.21 3.13 2.56 4.18 4.06 2.96
PBDT 1.83 4.18 -56.22 6.97 6.27 11.16 6.90 4.71 46.50
Depreciation 0.01 0.01 0.00 0.03 0.03 0.00 0.03 0.07 -57.14
PBT 1.82 4.17 -56.35 6.94 6.24 11.22 6.87 4.64 48.06
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.18 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00
PAT 1.82 4.17 -56.35 6.94 6.24 11.22 5.69 4.64 22.63
Equity 40.00 40.00 0.00 40.00 40.00 0.00 40.00 40.00 0.00
PBIDTM(%) 8.47 11.02 -23.16 8.40 11.48 -26.80 7.80 9.59 -18.65
Peers